Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Thursday, 8 March 2018

Dura Vermeer and Heijmans in building consortium for European Medicines Agency new-build project

Heijmans NV    

Published: 17:46 CET 08-03-2018 /GlobeNewswire /Source: Heijmans NV / : HEIJM /ISIN: NL0009269109

Dura Vermeer and Heijmans in building consortium for European Medicines Agency new-build project

Dura Vermeer is involving Heijmans in realizing the European Medicines Agency (EMA) new-build project on the Zuidas in Amsterdam. Together, both parties form a building consortium, with Dura Vermeer remaining the contract party for its client Rijksvastgoedbedrijf. Dura Vermeer has today signed the contract for the EMA building with State Secretary Knops (Ministry of the Interior and Kingdom Relations) and announced the partnership with Heijmans. The total contract value is €255 million.

Heijmans is part of the building consortium and, as an integral partner, will be jointly responsible for the structural and technical installations of the office building. Heijmans and Dura Vermeer are each responsible for 50 percent during the Design & Build period. Furthermore, Heijmans will play an explicit role during the 20-year Maintain phase. In addition to Heijmans, Dura Vermeer is working together with a team of consultants consisting of MVSA Architects, Fokkema & Partners Architects, OKRA landscape architects, Van Rossum, DWA and DGMR. SDR Elektrotechniek and Van Dorp Installations form part of the team for the installation work.

Amsterdam business park EMA
At the end of March 2019, the EMA will leave London as a result of the planned departure of the United Kingdom from the European Union. The Netherlands has been chosen as the new business park. The new building should accommodate around 900 employees from approximately 30 countries. In addition to workplaces, the building will house meeting rooms and congress facilities, and will have a gross floor area of 39,000 m2.

The EMA is responsible for the quality and safety of new medicines (for humans and animals) that are allowed on the European market.

About Heijmans
Heijmans is a listed company that combines activities related to property development, residential building, non-residential building, roads and civil engineering in the areas living, working and connecting. Our constant focus on quality improvements, innovation and integrated solutions enables us to generate added value for our clients. Heijmans realises projects for private consumers, companies and public sector bodies and together we are building the spatial contours of tomorrow. You will find additional information on www.heijmans.nl.

For more information / not for publication:

Mandy Snijders
+31 (0)73 543 52 17

Guido Peters
Investor Relations
+31 (0)73 543 52 17

Press release

This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: Heijmans NV, Postbus 2, Rosmalen 5240 BB, Nederland
If you would like to unsubscribe and stop receiving these e-mails click here.